banner
GalNAc-L96 intermediate, T4-Amine-TFA, Purity ≥98%
Inquiry

Cat. No.: X24-11-YM013

GalNAc-L96 intermediate, T4-Amine-TFA, Purity ≥98%

Synonym: 1924626-73-2; (2R,3R,4R,5R,6R)-5-Acetamido-2-(acetoxymethyl)-6-((5-((3-aminopropyl)amino)-5-oxopentyl)oxy)tetrahydro-2H-pyran-3,4-diyl diacetate--2,2,2-trifluoroacetaldehyde (1/1)

  • CAS Number: 1924626-73-2
img
Product Size
1 g; 2 g; 5 g; 10 g
Price
Datasheet
MSDS
Properties
Description
A triantennary GalNAc ligand, GalNAc-L96, which binds ASGPR efficiently, facilitates the production of GalNAc-siRNA with improved hepatocyte targeting. T4-Amine-TFA enhances the synthesis of GalNAc-L96 for use in targeted therapeutic agents.
Molecular Weight
601.57
Molecular Formula
C24H38F3N3O11
Form
Solid
Purity
≥98%, determined by HPLC.
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Conforms to structure, determined by 1H NMR.
Test Method
NMR; HPLC
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0